TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionordika AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,995
|
5,140
|
6,817 |
Financial expenses |
69
|
66
|
72 |
Earnings before taxes |
317
|
1,050
|
1,956 |
Total assets |
1,623
|
2,533
|
3,650 |
Current assets |
1,562
|
2,489
|
3,613 |
Current liabilities |
957
|
1,792
|
2,898 |
Equity capital |
655
|
722
|
752 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) | 10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
40.4%
|
28.5%
|
20.6% |
Turnover per employee | 682 | ||
Profit as a percentage of turnover |
7.9%
|
20.4%
|
28.7% |
Return on assets (ROA) |
23.8%
|
44.1%
|
55.6% |
Current ratio |
163.2%
|
138.9%
|
124.7% |
Return on equity (ROE) |
48.4%
|
145.4%
|
260.1% |
Change turnover |
-819
|
-1,318
|
-615 |
Change turnover % |
-17%
|
-20%
|
-8% |
Chg. No. of employees | -3 | ||
Chg. No. of employees % | -23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.